The FDA has proposed removing phenylephrine, a common ingredient in decongestants, due to its ineffectiveness, which may ...
Research from the College of Medicine provides promising insights into delaying the progression of Alzheimer’s disease for ...
Researchers at Texas A&M University have developed a nasal spray shown to delay disease progression in animals -- fueling hope it could one day work in humans.
Phenylephrine is a medication that’s been used to relieve nasal congestion caused by colds, allergies, and hay fever, per the ...
Common decongestants may soon be pulled from shelves. The Food and Drug Administration (FDA) announced Wednesday its proposal ...
The U.S. Food and Drug Administration is taking the first step to remove an ingredient in non-prescription cold medicines ...
The agreement grants ALK exclusive global rights to the neffy ® adrenaline (epinephrine) nasal spray, with exception of the USA ... rescue medication and many also fail to renew their prescription ...
The FDA had proposed removing phenylephrine, a widely used ingredient to treat nasal congestion, from over-the-counter cold ...
GIMOTI third quarter net product sales of $2.7 million, highest quarterly revenue ever with a 70% increase year-over-yearStrong cumulative ...
The FDA says oral phenylephrine, used in many over-the-counter cough and cold medicines, "is not effective as a nasal ...
The FDA said the proposed order is not final yet, which means companies can still market over-the-counter drugs containing ...
Jallah and his business partner, Shannon Turley, 46, admitted to ripping off insurance companies with phony prescriptions for headache sprays and ... “By billing for prescription medication ...